Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Oncology

AbbVie Shares Fall On Mixed Bag Q1 Results, Cuts FY22 Profit Guidance

AbbVie Inc (NYSE:ABBV) reports Q1 adjusted EPS of $3.16, higher than the $2.89 reported a year ago and beating the consensus of $3.14. Overall sales increased 4.1% Y/Y (5.4% on an operational basis) to $13.54 billion, missing the consensus of $13.63 billion. The immunology portfolio generated $6.14 billion in sales, +6.9% (+8.1%…

AstraZeneca Clocks Q1 COVID Vaccine Sales Of $1.2B, Keeps Overall FY22 Outlook

AstraZeneca Clocks Q1 COVID Vaccine Sales Of $1.2B, Keeps Overall FY22 Outlook

AstraZeneca Plc's (NASDAQ:AZN) total revenue jumped 60% Y/Y at CER to $11.39 billion in Q1 FY22, beating the consensus of $10.99 billion. The growth reflects the contribution of the Alexion medicines and several Vaxzevria contracts that are expected to complete the delivery by half year 2022. Core EPS came in at $1.89,…

Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Thursday

During Thursday, 849 stocks hit new 52-week lows.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Merck Clocks 50% Q1 Sales Growth Boosted By COVID-19 Treatment, Tightens FY22 EPS Outlook

Merck & Co Inc's (NYSE:MRK) Q1 sales reached $15.90 billion, +50% Y/Y, beating the consensus of $14.68 billion. Excluding the foreign exchange impact, revenues were up 52%. Pharmaceutical sales increased 53% to $14.11 billion, primarily driven by molnupiravir, oncology, vaccines, and hospital acute care products. Pharmaceutical sales growth, excluding Lagevrio sales, was…

‘I just need a space to cry.’ How hospitals have set up places where nurses can recharge

MIAMI -- Caring for very sick children daily can be emotionally taxing, even for professionals with years of experience. As front-line workers who also support grieving parents, nurses often cope with chronic stress.

Stephens & Co. Maintains Equal-Weight Rating for Universal Health Services: Here's What You Need To Know

Stephens & Co. has decided to maintain its Equal-Weight rating of Universal Health Services (NYSE:UHS) and lower its price target from $150.00 to $135.00. Shares of Universal Health Services are trading down 0.72% over the last 24 hours, at $124.42 per share.

Stocks That Hit 52-Week Lows On Wednesday

Wednesday's session saw 784 companies set new 52-week lows.

inkl

Read news from The Economist, FT, and more,
with one subscription

Non-COVID Sales Boost Exact Sciences' Q1 Revenue; Revises FY22 Guidance

Non-COVID Sales Boost Exact Sciences' Q1 Revenue; Revises FY22 Guidance

Exact Sciences Corp's (NASDAQ:EXAS) Q1 revenues increased 21% Y/Y to $486.6 million, beating the average Wall Street estimate of $461.71 million. Excluding COVID-19 testing revenues, which dropped 15% to $27.4 million, Exact's Q1 revenue increased 24%. Screening revenues rose 28% to $306.5 million in Q1, while Precision Oncology revenues were up 18%…

12 Health Care Stocks Moving In Thursday's After-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Thursday

On Thursday, 236 companies hit new 52-week lows.

1 … 9 10 11 12

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

AstraZeneca Plc

Universal Health Services

Liberty Broadband

Blackrock Muniholdings

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play